Aptose Biosciences Inc

NASDAQ:APTO 3:59:56 PM EDT

3.71

-0.05 (-1.33%)

4:03:15 PM EDT: $3.89 +0.18 (+4.85%)

Aptose Biosciences Inc Stock, NASDAQ:APTO

251 Consumers Road, Suite 1105, Toronto, Ontario M2J 4R3

Canada

Phone: +1.647.479.9828

Number of Employees: 39

http://www.aptose.com

Description

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.